These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19702241)

  • 1. Evaluation of virtual screening as a tool for chemical genetic applications.
    Campagna-Slater V; Schapira M
    J Chem Inf Model; 2009 Sep; 49(9):2082-91. PubMed ID: 19702241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
    Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
    J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening - what does it give us?
    Köppen H
    Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T; Bergner A; Sheppard D; Hafenbradl D
    J Biomol Screen; 2012 Jan; 17(1):85-98. PubMed ID: 21990582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
    J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
    Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
    J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P; Saxena AK
    J Chem Inf Model; 2006; 46(1):39-51. PubMed ID: 16426038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
    Kuck D; Singh N; Lyko F; Medina-Franco JL
    Bioorg Med Chem; 2010 Jan; 18(2):822-9. PubMed ID: 20006515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput virtual screening of proteins using GRID molecular interaction fields.
    Sciabola S; Stanton RV; Mills JE; Flocco MM; Baroni M; Cruciani G; Perruccio F; Mason JS
    J Chem Inf Model; 2010 Jan; 50(1):155-69. PubMed ID: 19919042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eHiTS-to-VMD interface application. The search for tyrosine-tRNA ligase inhibitors.
    Eitner K; Gaweda T; Hoffmann M; Jura M; Rychlewski L; Barciszewski J
    J Chem Inf Model; 2007; 47(2):695-702. PubMed ID: 17381179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase.
    Luzhkov VB; Selisko B; Nordqvist A; Peyrane F; Decroly E; Alvarez K; Karlen A; Canard B; Qvist J
    Bioorg Med Chem; 2007 Dec; 15(24):7795-802. PubMed ID: 17888664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustering and classifying diverse HIV entry inhibitors using a novel consensus shape-based virtual screening approach: further evidence for multiple binding sites within the CCR5 extracellular pocket.
    Pérez-Nueno VI; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Nov; 48(11):2146-65. PubMed ID: 18942828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. StructRank: a new approach for ligand-based virtual screening.
    Rathke F; Hansen K; Brefeld U; Müller KR
    J Chem Inf Model; 2011 Jan; 51(1):83-92. PubMed ID: 21166393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening of Abl inhibitors from large compound libraries by support vector machines.
    Liu XH; Ma XH; Tan CY; Jiang YY; Go ML; Low BC; Chen YZ
    J Chem Inf Model; 2009 Sep; 49(9):2101-10. PubMed ID: 19689138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.